EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 139 filers reported holding EPIZYME INC in Q1 2021. The put-call ratio across all filers is 15.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,277,000 | -68.2% | 1,548,767 | -75.1% | 0.00% | -75.0% |
Q1 2022 | $7,153,000 | +46.4% | 6,219,821 | +218.3% | 0.00% | +100.0% |
Q4 2021 | $4,885,000 | +126.2% | 1,954,128 | +363.1% | 0.00% | +100.0% |
Q3 2021 | $2,160,000 | -63.3% | 421,932 | -40.5% | 0.00% | -75.0% |
Q2 2021 | $5,891,000 | +14.4% | 708,860 | +19.9% | 0.00% | 0.0% |
Q1 2021 | $5,150,000 | +120.6% | 591,297 | +175.1% | 0.00% | +300.0% |
Q4 2020 | $2,335,000 | -57.6% | 214,966 | -53.4% | 0.00% | -85.7% |
Q3 2020 | $5,503,000 | +18.0% | 461,258 | +53.4% | 0.01% | -30.0% |
Q1 2020 | $4,663,000 | +1404.2% | 300,646 | +2284.4% | 0.01% | – |
Q4 2019 | $310,000 | -97.4% | 12,609 | -98.9% | 0.00% | -100.0% |
Q3 2019 | $12,116,000 | +26.0% | 1,174,665 | +53.3% | 0.02% | +35.7% |
Q2 2019 | $9,614,000 | -56.3% | 766,091 | -56.8% | 0.01% | -57.6% |
Q1 2019 | $21,986,000 | +335.9% | 1,774,482 | +116.7% | 0.03% | +312.5% |
Q4 2018 | $5,044,000 | +261.1% | 818,800 | +521.5% | 0.01% | +300.0% |
Q3 2018 | $1,397,000 | +47.4% | 131,753 | +88.3% | 0.00% | +100.0% |
Q2 2018 | $948,000 | -93.7% | 69,979 | -91.8% | 0.00% | -95.0% |
Q1 2018 | $15,114,000 | +20.8% | 851,508 | -14.6% | 0.02% | +17.6% |
Q4 2017 | $12,508,000 | +3.0% | 996,687 | +56.4% | 0.02% | -5.6% |
Q3 2017 | $12,138,000 | +48.8% | 637,140 | +18.0% | 0.02% | +20.0% |
Q2 2017 | $8,155,000 | +99.3% | 540,084 | +126.3% | 0.02% | +114.3% |
Q1 2017 | $4,092,000 | +133.6% | 238,623 | +64.8% | 0.01% | +75.0% |
Q4 2016 | $1,752,000 | -35.2% | 144,822 | -47.3% | 0.00% | -20.0% |
Q3 2016 | $2,702,000 | -71.8% | 274,613 | -70.6% | 0.01% | -77.3% |
Q2 2016 | $9,576,000 | +8.1% | 935,156 | +28.0% | 0.02% | 0.0% |
Q1 2016 | $8,856,000 | +638.0% | 730,664 | +1361.3% | 0.02% | +1000.0% |
Q2 2015 | $1,200,000 | -9.0% | 50,000 | -28.8% | 0.00% | 0.0% |
Q1 2015 | $1,318,000 | -70.2% | 70,180 | -70.1% | 0.00% | -77.8% |
Q4 2014 | $4,428,000 | +235.2% | 234,640 | +381.5% | 0.01% | +200.0% |
Q3 2014 | $1,321,000 | -33.4% | 48,731 | -23.5% | 0.00% | -40.0% |
Q2 2014 | $1,984,000 | +675.0% | 63,740 | +466.0% | 0.01% | +400.0% |
Q1 2014 | $256,000 | – | 11,261 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |